Nuo Therapeutics, Inc | 2013 | FY | 3


Non-cash Investing and Financing transactions for years ended December 31 include:
 
 
 
 
2013
 
2012
Conversion of convertible debt to common stock
 
$
523,927
 
 
$
924,904
 
Preferred dividends paid by issuance of stock
 
 
—
 
 
 
82,500
 
Business combination:
 
 
  
 
 
 
  
 
Issuance of Series E liability
 
 
—
 
 
 
18,955,742
 
Issuance of contingent consideration
 
 
—
 
 
 
11,109,020
 
Issuance of replacement warrants
 
 
—
 
 
 
1,883,751
 
Common stock issued in satisfaction of subscription receivable
 
 
—
 
 
 
2,790,107
 
Effect of cancellation of escrowed shares
 
 
—
 
 
 
195,132
 
Obligation to issue shares for professional services
 
 
—
 
 
 
30,000
 
Effect of modification of convertible debt
 
 
151,032
 
 
 
—
 
Common Stock issued for committed equity financing facility
 
 
204,015
 
 
 
—
 
Warrants issued for term loan modification
 
 
151,758
 
 
 
—
 
Warrants issued for term loan
 
 
568,324
 
 
 
—
 
Common stock and warrants issued for release of security interest in patents
 
 
325,693
 
 
 
—
 
Warrants issued in connection with convertible debt
 
 
1,353,842
 
 
 
—
 
Derivative liability for embedded conversion option
 
 
965,484
 
 
 
—
 
Common stock issued for professional services
 
 
17,850
 
 
 
—
 
Common stock issued for settlement of contingency
 
 
39,150
 
 
 
—
 

us-gaap:DetailsOfNonmonetaryTransactionsTableTextBlock